FDA Approves Unknown Drug — CENTAUR PHARMS PVT

# FDA Approves New Generic Drug Application for Centaur Pharmaceuticals The FDA has approved ANDA220470 for Centaur Pharmaceuticals PVT, expanding the company's portfolio and potentially introducing competitive pricing pressure in its respective therapeutic category. The approval positions Centaur to capture market share in the generic drug segment, subject to manufacturing scale-up and distribution capabilities.